MYLAN 6090 MYLAN 6090 (Diltiazem Hydrochloride Extended-Release (SR) 90 mg)
Generic Name: diltiazem
Pill with imprint MYLAN 6090 MYLAN 6090 is Pink & White, Capsule-shape and has been identified as Diltiazem Hydrochloride Extended-Release (SR) 90 mg. It is supplied by Mylan Pharmaceuticals Inc..
Diltiazem Hydrochloride SR is used in the treatment of heart failure; angina pectoris prophylaxis; high blood pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem Hydrochloride SR 90 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 6090 MYLAN 6090
Diltiazem Hydrochloride Extended-Release (SR)
- Generic Name
- diltiazem
- Imprint
- MYLAN 6090 MYLAN 6090
- Strength
- 90 mg
- Color
- Pink & White
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Calcium channel blocking agents, Group iv antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
diethyl phthalate,
gelatin,
hypromelloses,
maltodextrin,
methacrylic acid - methyl methacrylate copolymer (1:2),
polyethylene glycol,
povidone,
propylene glycol,
silicon dioxide,
sodium lauryl sulfate,
ferrosoferric oxide,
titanium dioxide,
FD&C Red No. 40,
FD&C Blue No. 2,
FD&C Blue No. 1,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-6090 | Mylan Pharmaceuticals Inc. |
| 51079-0925 | UDL Laboratories Inc. |
More about Diltiazem Hydrochloride SR (diltiazem)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 1 Review
- Drug class: calcium channel blocking agents
Patient resources
- Other brands
- Cardizem, Cartia XT, Dilt-XR, Cardizem CD, ... +7 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.